By Thomas L. Knapp On July 24, US president Donald Trump signed four executive orders with an eye toward altering the way prescription drugs are priced and purchased in the United States. Three of the four orders embody good ideas that accord with the goals of think tanks supposedly supporting “free-market policy solutions” … Continue reading Executive Orders: This is Trump’s Brain on Drugs